What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Read More 4 minute read Pharma Industry News Scinai Immunotherapeutics secures Italian approval to advance Pincell acquisition and PC111 development Scinai Immunotherapeutics receives Italian Golden Power clearance for proposed Pincell buyout, moving closer to advancing PC111 monoclonal antibody program. byPallavi MadhirajuJune 7, 2025